Sakeen Kashem, MD, PhD

Stromal cells control the epithelial residence of DCs and memory T cells by regulated activation of TGF-β. (26901152)

Mohammed J, Beura LK, Bobr A, Astry B, Chicoine B, Kashem SW, Welty NE, Igyártó BZ, Wijeyesinghe S, Thompson EA, Matte C, Bartholin L, Kaplan A, Sheppard D, Bridges AG, Shlomchik WD, Masopust D, Kaplan DH PMID: 26901152

Generation of Th17 cells in response to intranasal infection requires TGF-β1 from dendritic cells and IL-6 from CD301b+ dendritic cells. (26417101)

Linehan JL, Dileepan T, Kashem SW, Kaplan DH, Cleary P, Jenkins MK PMID: 26417101

Nociceptive Sensory Fibers Drive Interleukin-23 Production from CD301b+ Dermal Dendritic Cells and Drive Protective Cutaneous Immunity. (26377898)

Kashem SW, Riedl MS, Yao C, Honda CN, Vulchanova L, Kaplan DH PMID: 26377898

Candida albicans morphology and dendritic cell subsets determine T helper cell differentiation. (25680275)

Kashem SW, Igyarto BZ, Gerami-Nejad M, Kumamoto Y, Mohammed JA, Jarrett E, Drummond RA, Zurawski SM, Zurawski G, Berman J, Iwasaki A, Brown GD, Kaplan DH PMID: 25680275

Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge. (25595784)

Cabrera-Perez J, Condotta SA, James BR, Kashem SW, Brincks EL, Rai D, Kucaba TA, Badovinac VP, Griffith TS PMID: 25595784

Langerhans cells require MyD88-dependent signals for Candida albicans response but not for contact hypersensitivity or migration. (22442445)

Haley K, Igyártó BZ, Ortner D, Bobr A, Kashem S, Schenten D, Kaplan DH PMID: 22442445

G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: roles of Mas-related genes MrgX1 and MrgX2. (21741965)

Kashem SW, Subramanian H, Collington SJ, Magotti P, Lambris JD, Ali H PMID: 21741965

PMX-53 as a dual CD88 antagonist and an agonist for Mas-related gene 2 (MrgX2) in human mast cells. (21441599)

Subramanian H, Kashem SW, Collington SJ, Qu H, Lambris JD, Ali H PMID: 21441599

Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo. (17293494)

Hassan S, Sainz IM, Khan MM, Bradford HN, Isordia-Salas I, Kashem SW, Sartor RB, Colman RW PMID: 17293494